Cannabis Strategic Ventures

As of June 30, 2020, Cannabis Strategic Ventures carries a market capitalization of 21.16M, placing it among publicly traded companies globally. Its enterprise value stands at 42.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2020, Cannabis Strategic Ventures has 268.88M shares outstanding.

These figures are as of June 30, 2020. The price-to-sales ratio is 3.69, and the price-to-book ratio stands at -3.11.

These figures are as of June 30, 2020. The EV/Sales ratio of 7.48 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 42.92M versus a market cap of 21.16M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2020, Cannabis Strategic Ventures maintains a current ratio of 0.27, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -327.39, indicating conservative leverage, while an interest coverage ratio of -431.57 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2020. Return on assets (ROA) is negative at -60.50, reflecting losses generated across the asset base. Inventory turnover of 2.57 indicates how many times Cannabis Strategic Ventures sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Cannabis Strategic Ventures's stock has gained approximately 469900.00% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.00.

Over the twelve months ended June 30, 2020, Cannabis Strategic Ventures generated 5.74M in revenue and converted that into -10.48M in net income, yielding earnings per share of -0.04. EBITDA reached -9.79M, while operating income came in at -8.38M.

As of June 30, 2020, Cannabis Strategic Ventures holds 456,630.00 in cash and equivalents against 22.20M in total debt, resulting in a net debt position of 12.77M. Total book value stands at -6.79M, with working capital of -12.47M providing operational flexibility.

Cannabis Strategic Ventures produced -8.56M in operating cash flow over the twelve months ended June 30, 2020. After subtracting -667,746.00 in capital expenditures, free cash flow totaled -9.23M - equivalent to -0.03 per share.

Over the twelve months ended June 30, 2020, Cannabis Strategic Ventures posted a gross margin of 23.90, reflecting its pricing power and cost economics. The operating margin of -146.02 and net profit margin of -182.55 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2020. Free cash flow yield is negative at -43.63: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -44.79, meaning Cannabis Strategic Ventures raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Cannabis Strategic Ventures's most recent stock split took place on April 29, 2015 with a 25:1 split ratio.

As of June 30, 2020, Cannabis Strategic Ventures has an Altman Z-Score of -5.42, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.